At a glance
ClinicalIndex Comparison RecordN/ACompleted· 172 enrolled
Drug / intervention
CAP-ITbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Durability of Adherence in Self-Management of HIV
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections·interventional·Posted Oct 8, 2009·Updated Mar 20, 2018
In Brief
A clinical study evaluating CAP-IT for HIV Infections. Completed, enrolled 172 participants across 2 sites in 2 countries.
Detailed Summary
Adherence to highly active antiretroviral therapy (HAART) is critical to successful treatment of HIV. This study tested an intervention that helps people infected with HIV take all their medications when and how they were supposed to.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesPeru, United States
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 2009
Enrollment StartJan 2010
Primary CompletionJan 2015
TodayJul 2026
First PostedOct 8, 2009
Enrollment StartJan 1, 2010
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 16.7 years ago
Interventions
CAP-ITbehavioral
Interventions designed to improve medication adherence, modified to specifically target people first starting highly active antiretroviral therapy (HAART)